In the pharmaceutical and life sciences sectors we are beginning to see how novel technologies, such as Machine-to-Machine (M2M) communication, Artificial Intelligence (AI), and the Industrial Internet of Things (IIoT) can play a role fostering innovation, improving product authentication, and transforming traditional operational models.
read more